Access to Medicine Foundation
The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Access to Medicine Index
Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.
Antimicrobial Resistance Benchmark
Tracks what the 30 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.
Access to Vaccines Index
Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
All the latest news about the Access to Medicine Foundation, our research programmes and engagement activities.
26 Jan 2015
22 Jan 2015
19 Jan 2015
View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.
Back to top |